NCT01382628

Brief Summary

This is a pilot study examining tendon collagen, collagen cross-linking, and markers of tendon extracellular matrix metabolism in the Achilles tendon of diabetic patients with ulcerations and amputations of the lower extremity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2011

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 27, 2011

Completed
7.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

August 20, 2019

Status Verified

August 1, 2019

Enrollment Period

7.9 years

First QC Date

June 21, 2011

Last Update Submit

August 19, 2019

Conditions

Keywords

DiabetesUlcersEquinus DeformityAmputationAchilles TendonLimb Loss

Outcome Measures

Primary Outcomes (1)

  • Structural and metabolic changes

    Characterize the structural and metabolic changes in the diabetic Achilles tendon as related to limb loss.

    1 year

Secondary Outcomes (1)

  • Relationship between collagen changes and system changes

    1 year

Study Arms (5)

Preulcerative plantar foot lesion

An area on the plantar foot, usually at the location of a bony prominence, that presents with erythema, significant hyperkeratosis, or thin, shiny skin.

Plantar ulcer no history of amputation

Plantar ulceration without a history of amputation or require an amputation.

Plantar ulcer and digital amputation

Plantar ulceration who will be undergoing a digital amputation.

Plantar ulcer and transmet amputation

Plantar ulceration who will be undergoing a transmetatarsal amputation.

Plantar ulceration and choparts

Plantar ulceration who will be undergoing Chopart's or more proximal amputation.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at Georgetown University Hospital, Center for Wound Healing or patients admitted to the Georgetown University Hospital (where the Limb service has been designated as a consulting or primary service) will be recruited into the study. Patients scheduled for an Achilles tendon lengthening procedure (as part of their SOC) will be recruited.

You may qualify if:

  • Type I or Type II Diabetes - diagnosed by their primary care provider
  • Demonstrates an equinus ankle deformity - Less than 0 degrees of passive dorsiflexion at the ankle joint with the knee extended or flexed.
  • Preulcerative plantar foot lesions - In the form of a callus with the epithelium intact
  • OR may also have the following:
  • Plantar ulceration without a history of amputations
  • Plantar ulceration with a history of digital amputations - or planned digital amputation
  • Plantar ulceration with a history of transmetatarsal amputations - or planned transmetatarsal amputation
  • Plantar ulceration with a history of Chopart's or more proximal amputation - or planned Chopart's or more proximal amputation

You may not qualify if:

  • Does not demonstrate an equinus ankle deformity
  • Cannot undergo elective surgery for any reason
  • History of Achilles tendon lengthening procedure performed
  • History of traumatic (acute or chronic) injury to the Achilles tendon

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Georgetown University Hospital Center for Wound Healing

Washington D.C., District of Columbia, 20007, United States

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

A tissue sample (20mg) of the Achilles tendon will be collected at this time. This tissue will be preserved in a dry ice container and shipped to Midwestern University for processing by the sub-investigator (CC). The specimens will be labeled numerically with a predetermined subject number. No patient identifying information will be on these samples.

MeSH Terms

Conditions

Diabetic FootEquinus DeformityDiabetes MellitusUlcer

Condition Hierarchy (Ancestors)

Diabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetes ComplicationsEndocrine System DiseasesDiabetic NeuropathiesTalipesFoot Deformities, AcquiredFoot DeformitiesMusculoskeletal DiseasesFoot Deformities, CongenitalLower Extremity Deformities, CongenitalLimb Deformities, CongenitalMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Paul J. Kim, DPM

    Georgetown University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor, Dept of Plastic Surgery Director of Research

Study Record Dates

First Submitted

June 21, 2011

First Posted

June 27, 2011

Study Start

May 1, 2011

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

August 20, 2019

Record last verified: 2019-08

Locations